[
  {
    "ts": "2025-10-02T15:36:12+00:00",
    "headline": "Why Charles River Laboratories (CRL) Stock Is Up Today",
    "summary": "Shares of lab services company Charles River Laboratories (NYSE:CRL) jumped 1.9% in the morning session after Barclays upgraded the company to Overweight from Equal-Weight and raised its price target.",
    "url": "https://finance.yahoo.com/news/why-charles-river-laboratories-crl-153612186.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "947488f4-b233-3cc6-a308-a66f66c8db9a",
      "content": {
        "id": "947488f4-b233-3cc6-a308-a66f66c8db9a",
        "contentType": "STORY",
        "title": "Why Charles River Laboratories (CRL) Stock Is Up Today",
        "description": "",
        "summary": "Shares of lab services company Charles River Laboratories (NYSE:CRL) jumped 1.9% in the morning session after Barclays upgraded the company to Overweight from Equal-Weight and raised its price target.",
        "pubDate": "2025-10-02T15:36:12Z",
        "displayTime": "2025-10-02T15:36:12Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/7509c571642c6ae9d1577bc3c4457c17",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "CRL Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/PLZRbui545u2bOcqTkunEw--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/7509c571642c6ae9d1577bc3c4457c17.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/YlRDliezLyxJ3r.biO59fw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/7509c571642c6ae9d1577bc3c4457c17.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/why-charles-river-laboratories-crl-153612186.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/why-charles-river-laboratories-crl-153612186.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CRL"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-02T13:40:31+00:00",
    "headline": "Nike upgraded, RH downgraded: Wall Street's top analyst calls",
    "summary": "Nike upgraded, RH downgraded: Wall Street's top analyst calls",
    "url": "https://finance.yahoo.com/news/nike-upgraded-rh-downgraded-wall-134031392.html",
    "source": "The Fly",
    "provider": "yfinance",
    "raw": {
      "id": "8105ec3b-ab34-3f0c-9fa5-04fc63febb63",
      "content": {
        "id": "8105ec3b-ab34-3f0c-9fa5-04fc63febb63",
        "contentType": "STORY",
        "title": "Nike upgraded, RH downgraded: Wall Street's top analyst calls",
        "description": "",
        "summary": "Nike upgraded, RH downgraded: Wall Street's top analyst calls",
        "pubDate": "2025-10-02T13:40:31Z",
        "displayTime": "2025-10-02T13:40:31Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/the_fly_169/5039a5ccc6ec98e1b92bc672330bfcec",
          "originalWidth": 1200,
          "originalHeight": 628,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/YHTvjvqtNAYBPYViMXYCow--~B/aD02Mjg7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/the_fly_169/5039a5ccc6ec98e1b92bc672330bfcec.cf.webp",
              "width": 1200,
              "height": 628,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/J3gfZRz3Jb2im4_aLYVn4g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/the_fly_169/5039a5ccc6ec98e1b92bc672330bfcec.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Fly",
          "url": "https://thefly.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/nike-upgraded-rh-downgraded-wall-134031392.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/nike-upgraded-rh-downgraded-wall-134031392.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "RACE"
            },
            {
              "symbol": "RH"
            },
            {
              "symbol": "BE"
            },
            {
              "symbol": "METCB"
            },
            {
              "symbol": "METCI"
            },
            {
              "symbol": "METCZ"
            },
            {
              "symbol": "MEDP"
            },
            {
              "symbol": "NKE"
            },
            {
              "symbol": "CTVA"
            },
            {
              "symbol": "TBCH"
            },
            {
              "symbol": "CRSR"
            },
            {
              "symbol": "MRCY"
            },
            {
              "symbol": "METC"
            },
            {
              "symbol": "RACE.MI"
            },
            {
              "symbol": "CHRW"
            },
            {
              "symbol": "CRL"
            },
            {
              "symbol": "EA"
            },
            {
              "symbol": "MDLZ"
            },
            {
              "symbol": "CC=F"
            },
            {
              "symbol": "CDNS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-02T13:34:26+00:00",
    "headline": "Life science tools Q3 preview: Barclays ups Charles River, downgrades Medpace",
    "summary": "Investing.com -- Barclays struck a more cautious but selective tone in its third-quarter U.S. life science tools and diagnostics preview, upgrading Charles River Laboratories while cutting Medpace.",
    "url": "https://finance.yahoo.com/news/life-science-tools-q3-preview-133426141.html",
    "source": "Investing.com",
    "provider": "yfinance",
    "raw": {
      "id": "44ee51d0-18c3-3126-80ad-af4eeab01627",
      "content": {
        "id": "44ee51d0-18c3-3126-80ad-af4eeab01627",
        "contentType": "STORY",
        "title": "Life science tools Q3 preview: Barclays ups Charles River, downgrades Medpace",
        "description": "",
        "summary": "Investing.com -- Barclays struck a more cautious but selective tone in its third-quarter U.S. life science tools and diagnostics preview, upgrading Charles River Laboratories while cutting Medpace.",
        "pubDate": "2025-10-02T13:34:26Z",
        "displayTime": "2025-10-02T13:34:26Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Investing.com",
          "url": "https://www.investing.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/life-science-tools-q3-preview-133426141.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/life-science-tools-q3-preview-133426141.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CRL"
            },
            {
              "symbol": "MEDP"
            },
            {
              "symbol": "BARC.L"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]